Miglustat HCl is an inhibitor of glucosylceramide synthase, primarily to treat Type I Gaucher disease (GD1).

Miglustat is an inhibitor of glucosylceramide synthase, primarily to treat Type I Gaucher disease (GD1).

Eliglustat tartrate, a specific inhibitor of glucosylceramide synthase, is under development as an oral substrate reduction therapy for Gaucher disease type 1 (GD1).

Eliglustat is a specific and potent inhibitor of glucosylceramide synthase.

Ibiglustat is a potent and selective glucosylceramide synthase inhibitor and ceramide glucosyltransferase inhibitor.

Miglustat-d9 HCl 是 Miglustat (hydrochloride) 的氘代物，是一种葡萄糖神经酰胺合成酶抑制剂，用于治疗 I 型戈谢病。

Genz-123346 is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1 and its IC50 for GM1 inhibition is 14 nM.

Cedrelone, a natural product isolated and purified from the barks of Cedrela toona with antifeedant, antimicrobial, insectidal, and significant cytotoxic activities, is a very potent inducers of apoptosis, it can cause cell cycle arrest.